Establishment of a bioluminescent MDA-MB-231 cell line for human triple-negative breast cancer research

By            

Oncology Reports, Vol. 27, Iss. 6, 2012-01 ,pp. : 1981-1989

Spandidos Publications

Access to resources Recommend Favorite

Regulation of c-fos transcription by chemopreventive isoflavonoids and lignans in MDA-MB-468 breast cancer cells

By Schultze-Mosgau M.-H.   Dale I.L.   Gant T.W.   Chipman J.K.   Kerr D.J.   Gescher A.  

European Journal of Cancer, Vol. 34, Iss. 9, 1998-08 ,pp. : 1425-1431

Elsevier

Access to resources Recommend Favorite

Influence of chemically modified tetracyclines on proliferation, invasion and migration properties of MDA-MB-468 human breast cancer cells

By Meng Qinghui   Xu Jingwen   Goldberg Itzhak   Rosen Eliot   Greenwald Robert   Fan Saijun  

Clinical and Experimental Metastasis, Vol. 18, Iss. 2, 2000-03 ,pp. : 139-146

Springer Publishing Company

Access to resources Recommend Favorite

Roles of p53 and p16 in triple-negative breast cancer

By Dang Daniel   Peng Yan  

Breast Cancer Management, Vol. 2, Iss. 6, 2013-11 ,pp. : 537-544

Future Medicine

Access to resources Recommend Favorite

Proteasome inhibitor bortezomib (PS-341) enhances RANKL-induced MDA-MB-231 breast cancer cell migration

By                  

Molecular Medicine Reports, Vol. 5, Iss. 2, 2012-01 ,pp. : 580-584

Spandidos Publications

Access to resources Recommend Favorite